MILWAUKEE, May 29, 2024 /PRNewswire/ -- Ademi LLP is investigating Surmodics (Nasdaq: SRDX) for possible breaches of fiduciary duty and other violations of law in its transaction with GTCR.Click here to learn how to join the https://www.ademilaw.com/case/surmodics-inc or call Guri Ademi toll-free at 866-264-3995.  There is no cost or obligation to you.In the transaction, Surmodics shareholders will receive only $43.00 per share in cash, for a total equity valuation of approximately $627 million. The transac ...